{"id":"https://openalex.org/W4405040468","doi":"https://doi.org/10.1182/blood-2024-205268","title":"Long-Term Efficacy Observation of Anti-BCMA CAR-T Cell Therapy Combined with Autologous Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma with Extramedullary Disease","display_name":"Long-Term Efficacy Observation of Anti-BCMA CAR-T Cell Therapy Combined with Autologous Hematopoietic Stem Cell Transplantation in Relapsed/Refractory Multiple Myeloma with Extramedullary Disease","publication_year":2024,"publication_date":"2024-11-05","ids":{"openalex":"https://openalex.org/W4405040468","doi":"https://doi.org/10.1182/blood-2024-205268"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2024-205268","doi":"https://doi.org/10.1182/blood-2024-205268","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2024-205268","pdf_url":"https://ashpublications.org/blood/article-pdf/144/Supplement 1/4763/2336058/blood-7521-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ashpublications.org/blood/article-pdf/144/Supplement 1/4763/2336058/blood-7521-main.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089086011","display_name":"Qi Deng","orcid":"https://orcid.org/0000-0002-3646-4953","observed_orcids":["https://orcid.org/0000-0002-3646-4953"]},"institutions":[{"id":"https://openalex.org/I2800200322","display_name":"Tianjin First Center Hospital","ror":"https://ror.org/02ch1zb66","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2800200322"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"QI Deng","raw_affiliation_strings":["1Tianjin First Central Hospital, Tianjin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Tianjin First Central Hospital, Tianjin, China","institution_ids":["https://openalex.org/I2800200322"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100353948","display_name":"Xin Li","orcid":"https://orcid.org/0000-0002-7837-7874","observed_orcids":["https://orcid.org/0000-0002-7837-7874"]},"institutions":[{"id":"https://openalex.org/I2800200322","display_name":"Tianjin First Center Hospital","ror":"https://ror.org/02ch1zb66","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2800200322"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xin Li","raw_affiliation_strings":["2Tianjin First Centre Hospital, Tianjin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Tianjin First Centre Hospital, Tianjin, China","institution_ids":["https://openalex.org/I2800200322"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100404169","display_name":"Qing Li","orcid":"https://orcid.org/0000-0003-2652-6070","observed_orcids":["https://orcid.org/0000-0003-2652-6070","https://orcid.org/0000-0003-1967-2280"]},"institutions":[{"id":"https://openalex.org/I2800200322","display_name":"Tianjin First Center Hospital","ror":"https://ror.org/02ch1zb66","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2800200322"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Qing Li","raw_affiliation_strings":["3Tianjin first central hospital of China, Tianjin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Tianjin first central hospital of China, Tianjin, China","institution_ids":["https://openalex.org/I2800200322"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115595049","display_name":"Jia Wang","orcid":"https://orcid.org/0000-0002-2330-8505","observed_orcids":["https://orcid.org/0000-0002-2330-8505"]},"institutions":[{"id":"https://openalex.org/I2800200322","display_name":"Tianjin First Center Hospital","ror":"https://ror.org/02ch1zb66","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2800200322"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jia Wang","raw_affiliation_strings":["4Department of Hematology, Tianjin First Central Hospital, Tianjin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Department of Hematology, Tianjin First Central Hospital, Tianjin, China","institution_ids":["https://openalex.org/I2800200322"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075011408","display_name":"Juan Mu","orcid":"https://orcid.org/0000-0003-2339-0892","observed_orcids":["https://orcid.org/0000-0003-2339-0892"]},"institutions":[{"id":"https://openalex.org/I2800200322","display_name":"Tianjin First Center Hospital","ror":"https://ror.org/02ch1zb66","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2800200322"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Juan Mu","raw_affiliation_strings":["5Department of Hematology, Tianjin First Central Hospital, Tianjin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Department of Hematology, Tianjin First Central Hospital, Tianjin, China","institution_ids":["https://openalex.org/I2800200322"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101569323","display_name":"Rui Cui","orcid":"https://orcid.org/0000-0002-4994-5262","observed_orcids":["https://orcid.org/0000-0002-4994-5262"]},"institutions":[{"id":"https://openalex.org/I2800200322","display_name":"Tianjin First Center Hospital","ror":"https://ror.org/02ch1zb66","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I2800200322"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Rui Cui","raw_affiliation_strings":["6Tianjin First center hospital, Tianjin, China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6Tianjin First center hospital, Tianjin, China","institution_ids":["https://openalex.org/I2800200322"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I2800200322"],"apc_list":{"value":5000,"currency":"USD","value_usd":5000},"apc_paid":null,"fwci":null,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"144","issue":"Supplement 1","first_page":"4763","last_page":"4763"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.6762999892234802,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10649","display_name":"Multiple Myeloma Research and Treatments","score":0.6762999892234802,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11491","display_name":"CAR-T cell therapy research","score":0.3156999945640564,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10137","display_name":"Multiple Sclerosis Research Studies","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/b-cell-maturation-antigen","display_name":"BCMA","score":0.7319999933242798},{"id":"https://openalex.org/keywords/car-t-cell-therapy","display_name":"CAR T-cell therapy","score":0.9750000238418579},{"id":"https://openalex.org/keywords/relapsed-refractory-multiple-myeloma","display_name":"relapsed/refractory multiple myeloma","score":0.9309999942779541},{"id":"https://openalex.org/keywords/extramedullary-disease","display_name":"extramedullary disease","score":0.9900000095367432},{"id":"https://openalex.org/keywords/autologous-stem-cell-transplantation","display_name":"autologous stem cell transplantation","score":0.9990000128746033},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.8989999890327454},{"id":"https://openalex.org/keywords/cd34-cell-collection","display_name":"CD34+ cell collection","score":0.6840000152587891},{"id":"https://openalex.org/keywords/cytokine-release-syndrome","display_name":"cytokine release syndrome","score":0.7009999752044678},{"id":"https://openalex.org/keywords/immune-effector-cell-associated-neurotoxicity-syndrome","display_name":"immune effector cell-associated neurotoxicity syndrome","score":0.890999972820282},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.609000027179718},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9700000286102295},{"id":"https://openalex.org/keywords/hematological-toxicity","display_name":"hematologic toxicity","score":0.5350000262260437},{"id":"https://openalex.org/keywords/long-term-efficacy","display_name":"long-term efficacy","score":0.5370000004768372},{"id":"https://openalex.org/keywords/relapse-prevention","display_name":"relapse prevention","score":0.5139999985694885},{"id":"https://openalex.org/keywords/measurable-residual-disease","display_name":"minimal residual disease","score":0.34200000762939453}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7181345820426941},{"id":"https://openalex.org/C2776364478","wikidata":"https://www.wikidata.org/wiki/Q467635","display_name":"Multiple myeloma","level":2,"score":0.6507467031478882},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.64959317445755},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.5823578834533691},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.5669122338294983},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5178002119064331},{"id":"https://openalex.org/C2779050716","wikidata":"https://www.wikidata.org/wiki/Q4826373","display_name":"Autologous stem-cell transplantation","level":3,"score":0.46313977241516113},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4244879484176636},{"id":"https://openalex.org/C2779972918","wikidata":"https://www.wikidata.org/wiki/Q1194520","display_name":"Graft-versus-host disease","level":3,"score":0.4151824712753296},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3539503216743469},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.34527817368507385},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.10754963755607605},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2024-205268","doi":"https://doi.org/10.1182/blood-2024-205268","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2024-205268","pdf_url":"https://ashpublications.org/blood/article-pdf/144/Supplement 1/4763/2336058/blood-7521-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1182/blood-2024-205268","doi":"https://doi.org/10.1182/blood-2024-205268","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2024-205268","pdf_url":"https://ashpublications.org/blood/article-pdf/144/Supplement 1/4763/2336058/blood-7521-main.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-3","ki-jl-3","medline","norway-2"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"sustainable_development_goals_aurora":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.8199999928474426}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4405040468.pdf"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2605785415","https://openalex.org/W2889043118","https://openalex.org/W2572465956","https://openalex.org/W3201264842","https://openalex.org/W2043667488","https://openalex.org/W2290145250","https://openalex.org/W2970317558","https://openalex.org/W3031202510","https://openalex.org/W2521738172","https://openalex.org/W583323885"],"abstract_inverted_index":{"Background:":[0],"Although":[1],"the":[2,13,55,69,72,76,84,135,149,163,168,176,202,238,271,326,372,418,442,529,579,594,647,676,681,690,693,697],"objective":[3],"response":[4,248,251,262],"rate":[5,683],"(ORR)":[6],"was":[7,280,337,504],"significant,":[8],"more":[9],"than":[10,131,469,491],"half":[11],"of":[12,31,57,71,86,188,235,269,321,441,471,483,493,502,536,578,582,596,625,635,678,692,699],"relapsed/refractory":[14],"(R/R)":[15],"multiple":[16],"myeloma":[17],"(MM)":[18],"patients":[19,92,112,123,137,152,204,242,273,287,293,299,306,323,328,348,361,374,382,400,410,508,516,545,549,554,562,566,571,580],"received":[20,138,153,428],"anti-BCMA":[21,106,139,154,331,393,685],"CAR-T":[22,45,61,107,140,155,189,332,394,484,601,605,662,686],"cell":[23,46,51,62,141,156,333,395,432,606,663,687],"therapy":[24,63,81,142,157,236,456,599,607,664],"relapsed":[25,349],"within":[26],"one":[27,211,254,425],"year.":[28],"The":[29,267,278,319,335,358,460,481,498,522,532,638],"presence":[30],"R/R":[32,90,206,612,669],"MM":[33,58,91,207,613,670],"with":[34,39,65,144,205,609,615,619,632,666,672],"extramedullary":[35],"disease":[36,311,313,384],"(EMD)":[37],"associated":[38,618,631],"significantly":[40],"worse":[41],"survival":[42,170,174],"outcomes":[43],"following":[44],"infusion.":[47],"Autologous":[48],"hematopoietic":[49,430],"stem":[50,97,431],"transplantation":[52,433],"(Auto-HSCT)":[53],"is":[54,617,629],"cornerstone":[56],"treatment.":[59],"Anti-BCMA":[60,604,661],"combined":[64,143,608,665],"auto-HSCT":[66,145,610,667],"could":[67,82,674,695],"combine":[68,675],"advantages":[70,677],"two":[73,239,292,298,305,347,530,570,591,648,694],"therapies,":[74],"reducing":[75,680],"recurrence":[77,682],"rate.":[78],"This":[79],"combination":[80,276,356,598,691],"expand":[83,696],"scope":[85,698],"auto-HSCT.":[87,700],"Methods:":[88],"Eighteen":[89],"had":[93,113,124,208,383,401],"collected":[94,114,126],"peripheral":[95,100],"blood":[96,101],"cells":[98,103,117,129,485],"and":[99,120,166,172,181,193,253,304,352,444,449,458,462,479,514,539,552,560,569,622,644,689],"mononuclear":[102],"to":[104,214,368,389,417,658],"prepare":[105],"cells.":[108],"However,":[109,650],"only":[110,158,315,346,408],"8":[111],"enough":[115,127],"CD34+":[116,128],"(>1.0\u00d7106/kg,":[118],"1.5-6.6\u00d7106/kg),":[119],"other":[121,150,194,359],"10":[122],"not":[125],"(less":[130],"1.0\u00d7106/kg,":[132],"0-0.5\u00d7106/kg).":[133],"All":[134,397],"eight":[136,272,322,373,544],"(C-T":[146],"group),":[147],"while":[148],"ten":[151,327,390],"(C":[159],"group).":[160],"We":[161],"observed":[162],"clinical":[164,218],"responses":[165],"ORR,":[167,380],"overall":[169],"(OS)":[171],"progression-free":[173],"(PFS),":[175],"cytokine":[177],"release":[178],"syndrome":[179,185],"(CRS)":[180],"immune-effector":[182],"cell-associated":[183],"neurotoxicity":[184],"(ICANS),":[186],"expression":[187],"cells,":[190],"hematologic":[191],"toxicities":[192],"adverse":[195,655],"events.":[196],"Results:":[197],"In":[198,343],"our":[199,217],"study,":[200],"all":[201,270,325],"18":[203],"at":[209,350,365,387,414,452,475],"least":[210],"EMD":[212,268,320,403,616,673],"prior":[213,233],"enrolling":[215],"in":[216,224,264,282,316,324,340,375,421,466,472,488,494,506,511,519,528,543,557,574,589,593,611,646,668],"trial.":[219],"There":[220,437],"were":[221,438,464,486,524,541,640,652],"no":[222,439,653],"differences":[223,440],"age,":[225],"sex,":[226],"high-risk":[227],"cytogenetics,":[228],"ISS":[229],"stage":[230],"III,":[231],"median":[232],"lines":[234],"between":[237,446],"groups.":[240,531,649],"Seven":[241],"(7/8,":[243,555],"87.5%)":[244,556],"obtained":[245,258,290,296,302,309,379],"stringent":[246],"complete":[247,250],"(sCR)/":[249],"(CR),":[252],"patient":[255,426,614,671],"(1/8,":[256],"12.5%)":[257],"very":[259],"good":[260],"partial":[261],"(VGPR)":[263],"C-T":[265,283,344,447,467,489,512,558],"group.":[266,284,318,342,521,576],"disappeared":[274,329],"after":[275,330,355,392,455,684],"therapy.":[277,334,357,396,602],"ORR":[279,336,621],"100.0%":[281],"While,":[285],"four":[286,409,515,565],"(4/10,":[288,411,517,567],"40.0%)":[289,412,518,568],"CR,":[291],"(2/10,":[294,300,307,572],"20.0%)":[295,301,308,573],"VGPR,":[297],"PR,":[303],"stable":[310],"(SD)/progressive":[312],"(PD)":[314],"C":[317,341,376,422,450,473,495,520,575],"80.0%":[338],"(8/10)":[339],"group,":[345,513,559],"6":[351],"19":[353],"months":[354,391,454,477],"six":[360,453],"(6/8,":[362],"75.0%)":[363],"survived":[364,413],"CR":[366],"state":[367,416],"cutoff":[369,419],"date.":[370],"Of":[371],"group":[377,423,448,451,468,474,490,496],"who":[378,427],"five":[381,399,548],"progression":[385],"again":[386],"three":[388,507,561],"these":[398,590],"recurrent":[402],"or":[404,585,600],"new":[405],"EMD.":[406],"And":[407],"CR/VGPR":[415],"date":[420],"(including":[424],"allogeneic":[429],"as":[434],"salvage":[435],"treatment).":[436],"PFS":[443,461],"OS":[445,463],"(PC-T=0.305":[457],"PC=0.305).":[459],"higher":[465,487,620,633],"that":[470,492],"twelve":[476],"(PC-T=0.015":[478],"PC=0.030).":[480],"peaks":[482],"(P=0.022).":[497],"\u2265":[499,533],"grade":[500,534],"3":[501,535],"CRS":[503,643],"found":[505,542],"(4/8,":[509],"50.0%)":[510],"results":[523,639,656],"similar":[525,641],"for":[526,642],"ICANS":[527,645],"neutropenia,":[537],"anemia":[538],"thrombocytopenia":[540],"(8/8,":[546],"100.0%),":[547],"(5/8,":[550],"62.5%)":[551],"seven":[553],"(3/10,":[563],"30.0%),":[564],"None":[577],"died":[581],"bacterial":[583],"infections":[584],"invasive":[586],"fungal":[587],"diseases":[588],"groups":[592],"course":[595],"their":[597],"Conclusion:":[603],"longer":[623],"term":[624],"survival.":[626],"But":[627],"it":[628],"also":[630],"level":[634],"hematological":[636,659],"toxicity.":[637,660],"there":[651],"serious":[654],"due":[657],"both,":[679],"therapy,":[688]},"counts_by_year":[],"updated_date":"2026-09-24T07:57:37.273135","created_date":"2025-10-10T00:00:00"}